GlassScriptPhysician profile
Michael J Puk
NPI 1932153640
$2,373.91
in general payments reported to CMS, 2019-2025
19 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $119 · 2021: $294 · 2022: $330 · 2023: $478 · 2024: $383 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $775.69 | 2022-2025 | |
| Allergan, INC. | $248.03 | 2019-2022 | |
| Alcon Vision LLC | $246.48 | 2019-2025 | Tryptyr, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $149.74 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $148.22 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Biogen, INC. | $119.27 | 2022-2024 | Byooviz |
| Oyster Point Pharma, INC. | $113.14 | 2022-2023 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $102.60 | 2019-2024 | Eylea Hd, Eylea |
| Genentech USA, INC. | $79.98 | 2022-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $68.27 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $59.46 | 2024-2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.04 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $48.19 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $44.50 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $37.79 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $25.23 | 2022-2023 | |
| Rxsight INC | $24.09 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Shire North American Group INC | $14.37 | 2019 | |
| Harrow Eye, LLC | $13.82 | 2024 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Puk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.